Suppr超能文献

腹膜后软组织肉瘤的管理:单机构经验及文献综述

The management of retroperitoneal soft tissue sarcoma: a single institution experience with a review of the literature.

作者信息

Pirayesh A, Chee Y, Helliwell T R, Hershman M J, Leinster S J, Fordham M V, Poston G J

机构信息

Department of Surgery, Royal Liverpool University Hospital, Prescot St., Liverpool, L7 8XP, UK.

出版信息

Eur J Surg Oncol. 2001 Aug;27(5):491-7. doi: 10.1053/ejso.2001.1146.

Abstract

AIM

Ten percent of soft tissue sarcomas (STS) arise in the retroperitoneal tissues. The prognosis for patients with retroperitoneal sarcoma is poor with a 5-year survival rate between 12% and 70%. Stage at presentation, high histological grade, unresectable primary tumour and incomplete resection are associated with a less favourable outcome.

METHODS

Complete follow-up data were available on 22 patients who underwent surgery for retroperitoneal STS in our institution between 1990 and 2000. Patient, tumour and treatment variables were analysed including use of adjuvant therapy and survival status.

RESULTS

Eighteen patients underwent surgery for primary disease, four patients were treated for recurrent disease or metastases. Ten patients presented with pain, seven with an abdominal mass, other presentation included weight loss and haematuria. Thirteen patients presented with tumours larger than 10 cm. The tumours were seven liposarcomas, six leiomyosarcomas, three malignant fibrous histiocytomas, two rhabdomyosarcomas, two malignant schwannomas and two undifferentiated sarcomas. Six primary tumours were completely excised, five patients received radiotherapy and five received chemotherapy. Local recurrence rate was 45% and recurrence-free interval for 10 patients with recurrence was 11 months. Five patients received radiotherapy and five received chemotherapy. The median survival for patients with primary tumours was 36 months, and 5-year survival was 44%. Adjuvant therapy was not associated with higher survival rates.

CONCLUSION

This study re-emphasizes the poor outcome of patients with retroperitoneal STS. Adjuvant radiotherapy and chemotherapy do not appear to be any proven benefit and the single most important prognostic factor is aggressive successful en bloc resection of the primary tumour. Our resection rate and 5-year survival rates are comparable with previous reported UK series although lower than large reports from North American centres. This might partly be explained by difficulty in data collection in a retrospective analysis, but may reflect inadequate subspecialization in UK centres.

摘要

目的

10%的软组织肉瘤(STS)发生于腹膜后组织。腹膜后肉瘤患者的预后较差,5年生存率在12%至70%之间。就诊时的分期、高组织学分级、不可切除的原发性肿瘤以及不完全切除与预后较差相关。

方法

1990年至2000年间,在我们机构对22例行腹膜后STS手术的患者有完整的随访数据。分析了患者、肿瘤和治疗变量,包括辅助治疗的使用和生存状况。

结果

18例患者接受了原发性疾病手术,4例患者接受复发性疾病或转移灶治疗。10例患者出现疼痛,7例出现腹部肿块,其他表现包括体重减轻和血尿。13例患者的肿瘤大于10厘米。肿瘤包括7例脂肪肉瘤、6例平滑肌肉瘤、3例恶性纤维组织细胞瘤、2例横纹肌肉瘤、2例恶性神经鞘瘤和2例未分化肉瘤。6例原发性肿瘤被完全切除,5例患者接受了放疗,5例患者接受了化疗。局部复发率为45%,10例复发患者的无复发生存期为11个月。5例患者接受了放疗,5例患者接受了化疗。原发性肿瘤患者的中位生存期为36个月,5年生存率为44%。辅助治疗与更高的生存率无关。

结论

本研究再次强调了腹膜后STS患者的不良预后。辅助放疗和化疗似乎没有任何已证实的益处,最重要的预后因素是对原发性肿瘤进行积极的整块成功切除。我们的切除率和5年生存率与之前英国报道的系列相当,尽管低于北美中心的大型报道。这可能部分是由于回顾性分析中数据收集困难,但也可能反映了英国中心专科化不足。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验